← back to search

Akshay Vaishnaw

Alnylam Pharmaceuticals (United States) · US
🔎 Find collaborators in Molecular Biology · Physiology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Biology · Physiology
Research interest
Research interests include Amyloidosis: Diagnosis, Treatment, Outcomes, RNA Interference and Gene Delivery, Alzheimer's disease research and treatments, and Respiratory viral infections research.
h-index
43
citations
13,860
works
99
NIH funding
primary concept
Medicine
email

Recent publications

Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
New England Journal of Medicine 2021cited by 492position: middledoi
Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1
Clinical Journal of the American Society of Nephrology 2021cited by 79position: middledoi
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria
New England Journal of Medicine 2020cited by 587position: middledoi
Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis
Circulation 2019cited by 461position: middledoi
Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria
New England Journal of Medicine 2019cited by 254position: middledoi
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
New England Journal of Medicine 2018cited by 2,881position: middledoi
Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy
New England Journal of Medicine 2017cited by 356position: middledoi
Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study
Orphanet Journal of Rare Diseases 2015cited by 322position: middledoi
ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients
The Journal of Heart and Lung Transplantation 2015cited by 160position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Pushkal Garg · Alnylam Pharmaceuticals (United States)5 papers (2017–2021) · 3 papers (2015–2019) · 2 papers (2015–2019)Daniella Magen · Technion – Israel Institute of Technology2 papers (2021–2021)David Adams · San Francisco Department of Public Health2 papers (2015–2019)Amy Simon · Beam Therapeutics (United States)2 papers (2015–2019)Tracy L. McGregor · Vanderbilt University2 papers (2021–2021)Jaap W. Groothoff · Amsterdam Neuroscience2 papers (2021–2021)Brian R. Bettencourt · The University of Texas Southwestern Medical Center2 papers (2015–2015)William G. van’t Hoff · University of Amsterdam2 papers (2021–2021)John L. Berk · Boston University2 papers (2015–2019)Jiandong Lu · Guangzhou University of Chinese Medicine2 papers (2021–2021)Georges Deschênes · Institut des Maladies Génétiques Imagine2 papers (2021–2021)Pierre Cochat · Institut des Maladies Génétiques Imagine2 papers (2021–2021)John C. Lieske · Mayo Clinic2 papers (2021–2021) · 2 papers (2015–2019)Yaacov Frishberg · University of Wisconsin–Madison2 papers (2021–2021)Jae Bum Kim · Seoul National University1 papers (2019–2019)Alejandra González‐Duarte · New York University1 papers (2019–2019) · 1 papers (2021–2021)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Biology · Physiology →